Irinotecan-based chemo for paediatric rhabdomyosarcoma

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2007

Schlagwörter:	Irinotecan Vincristine Objective Response Rate Rhabdomyosarcoma Complete Response Rate

Anmerkung:	© Adis International Ltd 2007

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1581(2007), 1 vom: März, Seite 16-16
Übergeordnetes Werk:	volume:1581 ; year:2007 ; number:1 ; month:03 ; pages:16-16

Links:	Volltext

DOI / URN:	10.2165/00128413-200715810-00038

Katalog-ID:	SPR035281316

Internformat


LEADER	01000caa a22002652 4500
001	SPR035281316
003	DE-627
005	20230519172553.0
007	cr uuu---uuuuu
008	201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200715810-00038 \|2 doi
035			\|a (DE-627)SPR035281316
035			\|a (SPR)00128413-200715810-00038-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Irinotecan-based chemo for paediatric rhabdomyosarcoma
264		1	\|c 2007
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2007
650		4	\|a Irinotecan \|7 (dpeaa)DE-He213
650		4	\|a Vincristine \|7 (dpeaa)DE-He213
650		4	\|a Objective Response Rate \|7 (dpeaa)DE-He213
650		4	\|a Rhabdomyosarcoma \|7 (dpeaa)DE-He213
650		4	\|a Complete Response Rate \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1581(2007), 1 vom: März, Seite 16-16 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1581 \|g year:2007 \|g number:1 \|g month:03 \|g pages:16-16
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200715810-00038 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1581 \|j 2007 \|e 1 \|c 03 \|h 16-16

Indexfelder

matchkey_str	article:22306056:2007----::rntcnaeceoopeitira
hierarchy_sort_str	2007
publishDate	2007
allfields	10.2165/00128413-200715810-00038 doi (DE-627)SPR035281316 (SPR)00128413-200715810-00038-e DE-627 ger DE-627 rakwb eng Irinotecan-based chemo for paediatric rhabdomyosarcoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Irinotecan (dpeaa)DE-He213 Vincristine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Rhabdomyosarcoma (dpeaa)DE-He213 Complete Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1581(2007), 1 vom: März, Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1581 year:2007 number:1 month:03 pages:16-16 https://dx.doi.org/10.2165/00128413-200715810-00038 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1581 2007 1 03 16-16
spelling	10.2165/00128413-200715810-00038 doi (DE-627)SPR035281316 (SPR)00128413-200715810-00038-e DE-627 ger DE-627 rakwb eng Irinotecan-based chemo for paediatric rhabdomyosarcoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Irinotecan (dpeaa)DE-He213 Vincristine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Rhabdomyosarcoma (dpeaa)DE-He213 Complete Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1581(2007), 1 vom: März, Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1581 year:2007 number:1 month:03 pages:16-16 https://dx.doi.org/10.2165/00128413-200715810-00038 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1581 2007 1 03 16-16
allfields_unstemmed	10.2165/00128413-200715810-00038 doi (DE-627)SPR035281316 (SPR)00128413-200715810-00038-e DE-627 ger DE-627 rakwb eng Irinotecan-based chemo for paediatric rhabdomyosarcoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Irinotecan (dpeaa)DE-He213 Vincristine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Rhabdomyosarcoma (dpeaa)DE-He213 Complete Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1581(2007), 1 vom: März, Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1581 year:2007 number:1 month:03 pages:16-16 https://dx.doi.org/10.2165/00128413-200715810-00038 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1581 2007 1 03 16-16
allfieldsGer	10.2165/00128413-200715810-00038 doi (DE-627)SPR035281316 (SPR)00128413-200715810-00038-e DE-627 ger DE-627 rakwb eng Irinotecan-based chemo for paediatric rhabdomyosarcoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Irinotecan (dpeaa)DE-He213 Vincristine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Rhabdomyosarcoma (dpeaa)DE-He213 Complete Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1581(2007), 1 vom: März, Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1581 year:2007 number:1 month:03 pages:16-16 https://dx.doi.org/10.2165/00128413-200715810-00038 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1581 2007 1 03 16-16
allfieldsSound	10.2165/00128413-200715810-00038 doi (DE-627)SPR035281316 (SPR)00128413-200715810-00038-e DE-627 ger DE-627 rakwb eng Irinotecan-based chemo for paediatric rhabdomyosarcoma 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Irinotecan (dpeaa)DE-He213 Vincristine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Rhabdomyosarcoma (dpeaa)DE-He213 Complete Response Rate (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1581(2007), 1 vom: März, Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1581 year:2007 number:1 month:03 pages:16-16 https://dx.doi.org/10.2165/00128413-200715810-00038 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1581 2007 1 03 16-16
language	English
source	Enthalten in Inpharma weekly 1581(2007), 1 vom: März, Seite 16-16 volume:1581 year:2007 number:1 month:03 pages:16-16
sourceStr	Enthalten in Inpharma weekly 1581(2007), 1 vom: März, Seite 16-16 volume:1581 year:2007 number:1 month:03 pages:16-16
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Irinotecan Vincristine Objective Response Rate Rhabdomyosarcoma Complete Response Rate
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2007-03-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035281316
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035281316</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519172553.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200715810-00038</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035281316</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200715810-00038-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Irinotecan-based chemo for paediatric rhabdomyosarcoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2007</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Irinotecan</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vincristine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Objective Response Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rhabdomyosarcoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Complete Response Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1581(2007), 1 vom: März, Seite 16-16</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1581</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:16-16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200715810-00038</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1581</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">16-16</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Irinotecan-based chemo for paediatric rhabdomyosarcoma Irinotecan (dpeaa)DE-He213 Vincristine (dpeaa)DE-He213 Objective Response Rate (dpeaa)DE-He213 Rhabdomyosarcoma (dpeaa)DE-He213 Complete Response Rate (dpeaa)DE-He213
topic	misc Irinotecan misc Vincristine misc Objective Response Rate misc Rhabdomyosarcoma misc Complete Response Rate
spellingShingle	misc Irinotecan misc Vincristine misc Objective Response Rate misc Rhabdomyosarcoma misc Complete Response Rate Irinotecan-based chemo for paediatric rhabdomyosarcoma
topic_unstemmed	misc Irinotecan misc Vincristine misc Objective Response Rate misc Rhabdomyosarcoma misc Complete Response Rate
topic_browse	misc Irinotecan misc Vincristine misc Objective Response Rate misc Rhabdomyosarcoma misc Complete Response Rate
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Irinotecan-based chemo for paediatric rhabdomyosarcoma
ctrlnum	(DE-627)SPR035281316 (SPR)00128413-200715810-00038-e
title_full	Irinotecan-based chemo for paediatric rhabdomyosarcoma
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2007
contenttype_str_mv	txt
container_start_page	16
container_volume	1581
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200715810-00038
title_sort	irinotecan-based chemo for paediatric rhabdomyosarcoma
title_auth	Irinotecan-based chemo for paediatric rhabdomyosarcoma
abstract	© Adis International Ltd 2007
abstractGer	© Adis International Ltd 2007
abstract_unstemmed	© Adis International Ltd 2007
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Irinotecan-based chemo for paediatric rhabdomyosarcoma
url	https://dx.doi.org/10.2165/00128413-200715810-00038
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200715810-00038
up_date	2024-07-03T14:02:51.798Z
_version_	1803566838506848256
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035281316</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519172553.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200715810-00038</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035281316</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200715810-00038-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Irinotecan-based chemo for paediatric rhabdomyosarcoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2007</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Irinotecan</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vincristine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Objective Response Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rhabdomyosarcoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Complete Response Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1581(2007), 1 vom: März, Seite 16-16</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1581</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:16-16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200715810-00038</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1581</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">16-16</subfield></datafield></record></collection>
score	7.4002113

Nicht das Richtige dabei?

Schreiben Sie uns!

Irinotecan-based chemo for paediatric rhabdomyosarcoma

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?